Handelen Aeterna Zentaris - AEZS CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.1468 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.025457% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.003235% | ||||||||
| Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 0.01 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
Belangrijkste statistieken
| Prev. Close* | 2.7416 |
| Open* | 2.6119 |
| 1-Jaarlijkse Verandering* | 1268.92% |
| Dagelijks bereik* | 2.6119 - 2.7316 |
| 52 wekelijks bereik | 3.18-11.25 |
| Weekgemiddelde volume (10 dagen) | 370.00 |
| Gemiddeld volume (3 maanden) | 32.42K |
| Marktkapitalisatie | 17.97M |
| P/E Ratio | -100.00K |
| Uitstaande Aandelen | 4.86M |
| Omzet | 8.48M |
| EPS | -6.80 |
| Dividend (opbrengst %) | N/A |
| Beta | 1.71 |
| Volgende inkomsten datum | Aug 1, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| Jun 1, 2023 | 2.7416 | 0.0001 | 0.00% | 2.7415 | 2.7516 | 2.6917 |
| May 31, 2023 | 2.7416 | -0.0198 | -0.72% | 2.7614 | 2.7614 | 2.6418 |
| May 30, 2023 | 2.7316 | 0.0000 | 0.00% | 2.7316 | 2.7516 | 2.6817 |
| May 26, 2023 | 2.7815 | 0.0200 | 0.72% | 2.7615 | 2.8613 | 2.7614 |
| May 25, 2023 | 2.7714 | -0.1595 | -5.44% | 2.9309 | 2.9309 | 2.7714 |
| May 24, 2023 | 2.9909 | 0.0000 | 0.00% | 2.9909 | 3.0208 | 2.9808 |
| May 23, 2023 | 2.9908 | -0.0100 | -0.33% | 3.0008 | 3.0408 | 2.9907 |
| May 22, 2023 | 2.8911 | 0.0499 | 1.76% | 2.8412 | 2.9909 | 2.8312 |
| May 19, 2023 | 2.9311 | 0.1896 | 6.92% | 2.7415 | 2.9510 | 2.7415 |
| May 18, 2023 | 2.8014 | 0.1995 | 7.67% | 2.6019 | 2.9410 | 2.6019 |
| May 17, 2023 | 2.7315 | -0.0100 | -0.36% | 2.7415 | 2.7915 | 2.4823 |
| May 16, 2023 | 2.7416 | -0.1495 | -5.17% | 2.8911 | 2.9709 | 2.6717 |
| May 15, 2023 | 2.9011 | 0.0200 | 0.69% | 2.8811 | 2.9809 | 2.8811 |
| May 12, 2023 | 2.8911 | -0.1396 | -4.61% | 3.0307 | 3.0307 | 2.8312 |
| May 11, 2023 | 2.9610 | 0.0002 | 0.01% | 2.9608 | 2.9909 | 2.9608 |
| May 10, 2023 | 3.0407 | 0.0599 | 2.01% | 2.9808 | 3.0705 | 2.9808 |
| May 9, 2023 | 3.0706 | 0.0699 | 2.33% | 3.0007 | 3.0906 | 2.7514 |
| May 8, 2023 | 3.1005 | -0.0098 | -0.32% | 3.1103 | 3.2301 | 3.0705 |
| May 5, 2023 | 3.1105 | 0.1396 | 4.70% | 2.9709 | 3.2003 | 2.9708 |
| May 4, 2023 | 2.9709 | 0.1297 | 4.56% | 2.8412 | 3.0008 | 2.8013 |
Aeterna Zentaris Events
| Tijd (UTC) (UTC) | Land | Evenement |
|---|---|---|
| Wednesday, June 14, 2023 | ||
| Tijd (UTC) (UTC) 14:00 | Land US
| Evenement Aeterna Zentaris Inc Annual Shareholders Meeting Aeterna Zentaris Inc Annual Shareholders MeetingForecast -Previous - |
| Friday, July 14, 2023 | ||
| Tijd (UTC) (UTC) 14:00 | Land US
| Evenement Aeterna Zentaris Inc Annual Shareholders Meeting Aeterna Zentaris Inc Annual Shareholders MeetingForecast -Previous - |
| Tuesday, August 1, 2023 | ||
| Tijd (UTC) (UTC) 10:59 | Land US
| Evenement Q2 2023 Aeterna Zentaris Inc Earnings Release Q2 2023 Aeterna Zentaris Inc Earnings ReleaseForecast -Previous - |
| Wednesday, November 1, 2023 | ||
| Tijd (UTC) (UTC) 12:30 | Land US
| Evenement Q3 2023 Aeterna Zentaris Inc Earnings Release Q3 2023 Aeterna Zentaris Inc Earnings ReleaseForecast -Previous - |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totale inkomsten | 5.64 | 5.26 | 3.652 | 0.532 | 26.881 |
| Inkomsten | 5.64 | 5.26 | 3.652 | 0.532 | 26.881 |
| Totale bedrijfskosten | 29.243 | 13.931 | 9.358 | 10.774 | 18.439 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 8.225 | 5.916 | 4.759 | 6.608 | 11.988 |
| Onderzoek & Ontwikkeling | 12.506 | 6.558 | 1.491 | 1.807 | 2.889 |
| Depreciation / Amortization | 0.005 | 0.016 | 0.015 | 0.037 | 0.058 |
| Bedrijfsresultaat | -23.603 | -8.671 | -5.706 | -10.242 | 8.442 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | 0.875 | 0.208 | 0.553 | 0.087 | 0.656 |
| Overige, Netto | 0.001 | -0.014 | 0.43 | 3.925 | 0.541 |
| Netto inkomen voor belastingen | -22.727 | -8.477 | -4.723 | -6.23 | 9.639 |
| Netto inkomen na belastingen | -22.727 | -8.368 | -5.118 | -6.042 | 4.187 |
| Netto inkomen voor extra. Posten | -22.727 | -8.368 | -5.118 | -6.042 | 4.187 |
| Totale buitengewone posten | |||||
| Netto inkomen | -22.727 | -8.368 | -5.118 | -6.042 | 4.187 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -22.727 | -8.368 | -5.118 | -6.042 | 4.187 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -22.727 | -8.368 | -5.118 | -6.042 | 4.187 |
| Verwaterd Netto Inkomen | -22.727 | -8.368 | -5.118 | -6.042 | 4.187 |
| Verwaterd Gewogen Gemiddelde Aandelen | 4.85588 | 4.59698 | 1.64333 | 0.69978 | 0.68139 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -4.68031 | -1.82033 | -3.11441 | -8.63415 | 6.14477 |
| Verwaterde Genormaliseerde Winst per Aandeel | -2.96074 | -1.82033 | -3.25602 | -7.98581 | 7.03726 |
| Ongebruikelijke uitgaven (inkomsten) | 8.35 | 0 | -0.358 | 0.698 | 1.4 |
| Kosten van opbrengsten, totaal | 0.157 | 0.09 | 2.317 | 0.41 | 2.104 |
| Brutowinst | 5.483 | 5.17 | 1.335 | 0.122 | 24.777 |
| Other Operating Expenses, Total | 1.351 | 1.134 | 1.214 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 2.128 | 2.485 | 1.86 | -0.222 | 1.517 |
| Inkomsten | 2.128 | 2.485 | 1.86 | -0.222 | 1.517 |
| Kosten van opbrengsten, totaal | 0.017 | 0.051 | 0.014 | 0.013 | 0.079 |
| Brutowinst | 2.111 | 2.434 | 1.846 | -0.235 | 1.438 |
| Totale bedrijfskosten | 6.335 | 14.838 | 5.581 | 4.494 | 4.33 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 2.306 | 2.834 | 2.057 | 1.781 | 1.558 |
| Onderzoek & Ontwikkeling | 4.012 | 4.425 | 3.293 | 2.398 | 2.39 |
| Bedrijfsresultaat | -4.207 | -12.353 | -3.721 | -4.716 | -2.813 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -0.059 | -0.098 | 0.301 | 0.502 | 0.174 |
| Overige, Netto | 0.011 | 0 | 0 | -0.002 | -0.001 |
| Netto inkomen voor belastingen | -4.255 | -12.451 | -3.42 | -4.216 | -2.64 |
| Netto inkomen na belastingen | -4.255 | -12.451 | -3.42 | -4.216 | -2.64 |
| Netto inkomen voor extra. Posten | -4.255 | -12.451 | -3.42 | -4.216 | -2.64 |
| Netto inkomen | -4.255 | -12.451 | -3.42 | -4.216 | -2.64 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -4.255 | -12.451 | -3.42 | -4.216 | -2.64 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -4.255 | -12.451 | -3.42 | -4.216 | -2.64 |
| Verwaterd Netto Inkomen | -4.255 | -12.451 | -3.42 | -4.216 | -2.64 |
| Verwaterd Gewogen Gemiddelde Aandelen | 4.85588 | 4.85588 | 4.85588 | 4.85588 | 4.85588 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -0.87626 | -2.56411 | -0.7043 | -0.86823 | -0.54367 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Verwaterde Genormaliseerde Winst per Aandeel | -0.87626 | -0.84454 | -0.7043 | -0.86823 | -0.54367 |
| Ongebruikelijke uitgaven (inkomsten) | 8.35 | ||||
| Other Operating Expenses, Total | -0.822 | 0.217 | 0.302 | 0.303 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 55.488 | 70.82 | 27.614 | 10.91 | 16.256 |
| Geldmiddelen en kortetermijnbeleggingen | 50.611 | 65.3 | 24.271 | 7.838 | 14.512 |
| Cash | 50.611 | 55.6 | 23.92 | ||
| Geldmiddelen & Equivalenten | 0 | 9.7 | 0.351 | 7.838 | 14.512 |
| Totale Vorderingen, Netto | 2.16 | 3.675 | 2.282 | 0.658 | 0.294 |
| Accounts Receivable - Trade, Net | 0.403 | 0.877 | 1.19 | 0.21 | 0.142 |
| Prepaid Expenses | 2.426 | 1.75 | 1.021 | 1.211 | 1.21 |
| Total Assets | 56.026 | 80.102 | 37.005 | 19.981 | 25.011 |
| Property/Plant/Equipment, Total - Net | 0.216 | 0.192 | 0.179 | 0.617 | 0.065 |
| Property/Plant/Equipment, Total - Gross | 1.274 | 1.177 | 1.19 | 1.64 | 2.142 |
| Accumulated Depreciation, Total | -1.058 | -0.985 | -1.011 | -1.023 | -2.077 |
| Goodwill, Net | 0 | 8.13 | 8.815 | 8.05 | 8.21 |
| Intangibles, Net | 0 | 0.625 | 0.059 | 0.04 | 0.062 |
| Other Long Term Assets, Total | 0.322 | 0.335 | 0.338 | 0.364 | 0.418 |
| Total Current Liabilities | 7.044 | 7.766 | 4.742 | 5.659 | 5.596 |
| Accounts Payable | 2.038 | 0.934 | 1.187 | 1.087 | 1.282 |
| Accrued Expenses | 1.79 | 1.738 | 1.012 | 0.939 | 0.946 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 3.102 | 4.964 | 2.408 | 2.985 | 3.368 |
| Total Liabilities | 20.25 | 27.116 | 23.794 | 22.444 | 23.104 |
| Total Long Term Debt | 0.065 | 0.031 | 0.049 | 0.255 | 0 |
| Other Liabilities, Total | 13.141 | 19.319 | 19.003 | 16.53 | 17.508 |
| Total Equity | 35.776 | 52.986 | 13.211 | -2.463 | 1.907 |
| Common Stock | 293.41 | 293.41 | 235.008 | 224.528 | 222.335 |
| Retained Earnings (Accumulated Deficit) | -346.999 | -329.534 | -310.257 | -316.891 | -309.781 |
| Other Equity, Total | 89.365 | 89.11 | 88.46 | 89.9 | 89.353 |
| Total Liabilities & Shareholders’ Equity | 56.026 | 80.102 | 37.005 | 19.981 | 25.011 |
| Total Common Shares Outstanding | 4.85588 | 4.85588 | 2.50714 | 0.79978 | 0.65763 |
| Total Inventory | 0.229 | 0.073 | 0.021 | 1.203 | 0.24 |
| Current Port. of LT Debt/Capital Leases | 0.114 | 0.13 | 0.135 | 0.648 | |
| Capital Lease Obligations | 0.065 | 0.031 | 0.049 | 0.255 | |
| Other Current Assets, Total | 0.062 | 0.022 | 0.019 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 50.708 | 55.488 | 58.61 | 63.173 | 67.097 |
| Geldmiddelen en kortetermijnbeleggingen | 46.56 | 50.611 | 53.816 | 58.157 | 63.596 |
| Geldmiddelen & Equivalenten | 46.56 | 50.611 | 53.816 | 58.157 | 63.596 |
| Totale Vorderingen, Netto | 2.007 | 2.16 | 2.082 | 2.296 | 2.173 |
| Accounts Receivable - Trade, Net | 0.557 | 0.403 | 0.383 | 0.49 | 0.302 |
| Total Inventory | 0.227 | 0.229 | 0.238 | 0.261 | 0.278 |
| Prepaid Expenses | 1.914 | 2.426 | 2.4 | 2.37 | 0.907 |
| Other Current Assets, Total | 0.062 | 0.074 | 0.089 | 0.143 | |
| Total Assets | 51.282 | 56.026 | 66.606 | 71.825 | 76.344 |
| Property/Plant/Equipment, Total - Net | 0.248 | 0.216 | 0.125 | 0.156 | 0.198 |
| Goodwill, Net | 0 | 7.034 | 7.487 | 7.977 | |
| Intangibles, Net | 0 | 0.537 | 0.573 | 0.612 | |
| Other Long Term Assets, Total | 0.326 | 0.322 | 0.3 | 0.436 | 0.46 |
| Total Current Liabilities | 6.434 | 7.044 | 5.968 | 6.407 | 5.666 |
| Accounts Payable | 2.038 | 0.72 | 0.938 | 1.022 | |
| Accrued Expenses | 1.79 | 1.567 | 1.697 | 1.773 | |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.134 | 0.114 | 0.073 | 0.106 | 0.143 |
| Other Current Liabilities, Total | 2.17 | 3.102 | 3.608 | 3.666 | 2.728 |
| Total Liabilities | 20.074 | 20.25 | 17.188 | 17.531 | 23.185 |
| Total Long Term Debt | 0.076 | 0.065 | 0.016 | 0.016 | 0.022 |
| Capital Lease Obligations | 0.076 | 0.065 | 0.016 | 0.016 | 0.022 |
| Other Liabilities, Total | 13.564 | 13.141 | 11.204 | 11.108 | 17.497 |
| Total Equity | 31.208 | 35.776 | 49.418 | 54.294 | 53.159 |
| Common Stock | 293.41 | 293.41 | 293.41 | 293.41 | 293.41 |
| Retained Earnings (Accumulated Deficit) | -351.416 | -346.999 | -333.579 | -328.365 | -329.425 |
| Other Equity, Total | 89.214 | 89.365 | 89.587 | 89.249 | 89.174 |
| Total Liabilities & Shareholders’ Equity | 51.282 | 56.026 | 66.606 | 71.825 | 76.344 |
| Total Common Shares Outstanding | 4.85588 | 4.85588 | 4.85588 | 4.85588 | 4.85588 |
| Property/Plant/Equipment, Total - Gross | 1.274 | ||||
| Accumulated Depreciation, Total | -1.058 | ||||
| Payable/Accrued | 4.13 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | -22.727 | -8.368 | -5.118 | -6.042 | 4.187 |
| Geldmiddelen uit Operationele Activiteiten | -13.68 | -8.581 | -4.129 | -10.725 | 6.825 |
| Geldmiddelen uit Operationele Activiteiten | 0.135 | 0.145 | 0.232 | 0.315 | 0.058 |
| Niet-Geldelijke Posten | 7.477 | -1.253 | -0.197 | -2.554 | -2.705 |
| Veranderingen in het Operationeel Kapitaal | 1.435 | 0.895 | 0.954 | -2.444 | 1.806 |
| Geldmiddelen uit Investeringsactiviteiten | -0.012 | -0.658 | 0.056 | 0.05 | -0.035 |
| Kapitaaluitgaven | -0.011 | -0.639 | 0 | -0.009 | |
| Overige Cash Flow investeringsposten, Totaal | -0.001 | -0.019 | 0.056 | 0.05 | -0.026 |
| Geldmiddelen uit Financieringsactiviteiten | -0.118 | 51.037 | 20.468 | 3.893 | 0 |
| Financiering van Cash Flow Posten | 0.016 | -3.123 | -2.767 | -0.795 | |
| Uitgifte (Aflossing) van aandelen, netto | 0 | 54.287 | 23.5 | 5.302 | 0 |
| Wisselkoerseffecten | -0.879 | -0.769 | 0.038 | 0.108 | -0.058 |
| Nettowijziging in Geldmiddelen | -14.689 | 41.029 | 16.433 | -6.674 | 6.732 |
| Deferred Taxes | 0 | 3.479 | |||
| Uitgifte (Aflossing) van Schulden, Netto | -0.134 | -0.127 | -0.265 | -0.614 | |
| Cash Taxes Paid | -0.831 | 1.605 | 1.448 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -4.255 | -22.727 | -10.276 | -6.856 | -2.64 |
| Cash From Operating Activities | -4.061 | -13.68 | -10.256 | -6.311 | -1.461 |
| Cash From Operating Activities | 0.04 | 0.135 | 0.104 | 0.071 | 0.036 |
| Non-Cash Items | -0.607 | 7.477 | -1.168 | -0.62 | -0.864 |
| Cash Taxes Paid | 0 | -0.831 | -0.83 | -0.83 | -0.881 |
| Changes in Working Capital | 0.761 | 1.435 | 1.084 | 1.094 | 2.007 |
| Cash From Investing Activities | -0.002 | -0.012 | -0.053 | -0.048 | -0.006 |
| Capital Expenditures | -0.002 | -0.011 | -0.057 | -0.048 | -0.006 |
| Cash From Financing Activities | -0.038 | -0.118 | -0.101 | -0.068 | -0.034 |
| Financing Cash Flow Items | 0.016 | 0 | 0 | 0 | |
| Issuance (Retirement) of Stock, Net | 0 | 0 | 0 | 0 | |
| Issuance (Retirement) of Debt, Net | -0.038 | -0.134 | -0.101 | -0.068 | -0.034 |
| Foreign Exchange Effects | 0.05 | -0.879 | -1.074 | -0.716 | -0.203 |
| Net Change in Cash | -4.051 | -14.689 | -11.484 | -7.143 | -1.704 |
| Other Investing Cash Flow Items, Total | -0.001 | 0.004 | 0 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| Morgan Stanley & Co. LLC | Research Firm | 0.3303 | 16040 | 1700 | 2023-03-31 | MED |
| Intracoastal Capital, L.L.C. | Corporation | 0.2388 | 11594 | 11594 | 2021-12-31 | |
| Engel (Juergen) | Individual Investor | 0.1123 | 5453 | 3040 | 2022-05-23 | |
| Paulini (Klaus) | Individual Investor | 0.0865 | 4200 | 0 | 2023-05-09 | |
| Edmond de Rothschild Asset Management (France) S.A. | Investment Advisor | 0.0824 | 4000 | 0 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.0754 | 3659 | 0 | 2023-04-30 | LOW |
| Turpin (Dennis) | Individual Investor | 0.0729 | 3541 | -1280 | 2023-05-09 | |
| Group One Trading, L.P. | Research Firm | 0.0618 | 2999 | -10295 | 2023-03-31 | HIGH |
| RBC Dominion Securities, Inc. | Investment Advisor | 0.0356 | 1729 | 1153 | 2023-03-31 | LOW |
| Egbert (Carolyn) | Individual Investor | 0.0263 | 1276 | 0 | 2023-05-09 | |
| J.P. Morgan Securities LLC | Research Firm | 0.0171 | 832 | 80 | 2023-03-31 | MED |
| National Bank of Canada | Bank and Trust | 0.0098 | 476 | 0 | 2023-03-31 | HIGH |
| Advisor Group, Inc | Investment Advisor | 0.0048 | 234 | 0 | 2023-03-31 | LOW |
| Wells Fargo Advisors | Research Firm | 0.0041 | 200 | 0 | 2023-03-31 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 0.0019 | 90 | 50 | 2023-03-31 | LOW |
| Truvestments Capital LLC | Investment Advisor | 0.0018 | 88 | 0 | 2023-03-31 | LOW |
| Focused Wealth Management, Inc. | Investment Advisor | 0.0012 | 60 | 0 | 2023-03-31 | MED |
| Morgan Stanley Canada Limited | Research Firm | 0.0007 | 32 | 0 | 2023-03-31 | MED |
| Tower Research Capital LLC | Hedge Fund | 0.0002 | 11 | -520 | 2023-03-31 | HIGH |
| NEXT Financial Group, Inc. | Investment Advisor | 0.0001 | 5 | 0 | 2021-12-31 |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group535K+
Handelaren
87K+
Actieve klanten per maand
$113M+
Maandelijks beleggingsvolume
$64M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
Handelscommissie
0
- 1:1
Hefboom
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
Aeterna Zentaris Company profile
Over Aeterna Zentaris
Aeterna Zentaris Inc. is een gespecialiseerd biofarmaceutisch bedrijf, dat zich bezighoudt met de commercialisering en ontwikkeling van therapeutica en diagnostische tests. Het belangrijkste product van de Vennootschap, Macrilen (macimorelin), is een orale test voor de diagnose van patiënten met een tekort aan groeihormoon bij volwassenen (AGHD). Macrilen (macimorelin) is een oraal beschikbare peptidomimetische ghrelinereceptoragonist die de afscheiding van groeihormoon stimuleert door binding aan de ghrelinereceptor (GHSR-1a) en wordt gebruikt in zowel endocrinologische als oncologische indicaties. De Vennootschap maakt ook gebruik van het klinische en overtuigende veiligheidsprofiel van macimoreline om het te ontwikkelen voor de diagnose van groeihormoondeficiëntie bij kinderen (CGHD). De Vennootschap ontwikkelt ook orale profylactische bacteriële vaccins tegen SARS-CoV-2, het virus dat COVID-19 veroorzaakt, en Chlamydia Trachomatis. De Vennootschap richt zich op de commercialisering van macimorelin in Azië en de rest van de wereld.
| Industry: | Biotechnology & Medical Research (NEC) |
315 Sigma Drive
SUMMERVILLE
NEW BRUNSWICK 29486
CA
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 535.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen